Research reveals mRNA COVID-19 vaccines may enhance cancer immunotherapy effectiveness, extending survival for lung and skin ...

Cardiovascular disease continues to be the leading cause of death worldwide. But advances in heart-failure therapeutics have ...

Messenger RNA (mRNA) therapeutics hold significant promise for the future of personalized cancer treatment, but persistent ...

COVID-19 vaccines were game changing during the course of the pandemic; now another benefit is emerging—the same vaccines are ...

Inside the Booming mRNA Therapeutics MarketThe mRNA Cancer Vaccines and Therapeutics Market has emerged as one of the most ...

Researchers can use messenger RNA to trigger the immune system to attack tumors. By stimulating cancer cells to produce a ...

The study, published in the journal Nature, showed the jabs provided an immunity boost that helped extend survival for ...

The observation that mRNA vaccines can sensitize tumors to immunotherapy has researchers eager to test how mRNA’s ability to activate the immune system could be harnessed in oncology.

According to Nova One Advisor, the global RNA therapeutics market size is calculated at USD 8.55 billion in 2025 and is ...

Understanding how to control stem cell differentiation has been a pivotal pursuit in biomedical research. Recent findings highlight the significant role of RNA condensates, particularly P-bodies, in ...

Scientists in NSW have developed a potential world-first mRNA vaccine to protect cattle from foot and mouth disease. The ...

A new mRNA platform targets tumors with precision, limits side effects, and converts immune-silent cancers into responsive ...